About Lipid Genomics

Dr. Rodriguez is a board certified endocrinologist with expertise in cholesterol disorders, heart disease, and genomics.

Dr. Rodriguez is the inventor for the patented lymphocyte activation gene-3 (LAG3) diagnostic and recombinant LAG3 biologic.

Lipid Genomics currently has two product lines under development.  All product development supports the mission to identify diagnostics and therapeutics targeted towards patients with acute and chronic inflammatory diseases, including patients with LAG3 deficiency and at high risk for heart disease.   With the recent FDA approval of antiLAG3 therapy, it is important that clinical oncologists are aware of LAG3 deficiency in their patients.